Pre-Conference Workshop Day
Monday 9, June 2025
08:30 am Check In & Breakfast
9:30 - 12:30 Workshop A
Optimizing Evidence Generation in Early Clinical Stages to Enhance the Value Proposition for Market Access & Reimbursement
The value of optimizing evidence generation in early stages comes with its fair share of problems such as a lack of shared clinical trial infrastructure, resource allocation issues, and lack of effective cross-functional collaboration. How can we overcome these challenges?
This workshop will cover:
- Discover how incorporating real-world evidence early can strengthen clinical trial design and endpoint selection
- Explore strategies to align early evidence generation with payer and regulator expectations to support market access and reimbursement discussions
- Learn best practices for leveraging early-stage data to build robust value propositions and accelerate time-to-market
Workshop Leaders
Lene Hammer Helmich
Director, Head of RWE & Epidemiology
Lundbeck
Joan Mendivil
Head Evidence & Outcomes
Pharvaris
12:30 pm Lunch
13:30 - 16:30pm Workshop B
Maximizing Synergies Between Industry & Public Research to Elevate RWE Utility
The importance of industry and public research collaboration is being increasingly recognized. What are the current barriers in fostering collaboration between industry and public research institutions? How can we identify best practices for data sharing? How can we co-develop methodologies to leverage collective expertise to drive innovation and informed decision making?
This workshop will cover:
- Explore strategies to strengthen collaboration between industry and public research entities to enhance the quality and scope of real-world evidence (RWE)
- Learn how to optimize data sharing, infrastructure, and expertise to maximize theutility and impact of RWE across both sectors
- Discover methods for aligning industry goals with public research priorities to ensure that RWE supports both commercial needs and societal health outcomes
Workshop Leaders
Onyinye Diribe
HEOR Real World Evidence Lead
Sanofi
Marcus Lawrance
Director - Global Oncology & Data Strategy
AstraZeneca
Tina Roblek
Evidence Generation & Management Lead Managed Care Organization &
Electrical Engineering
Takeda
Katoo Muylle
Real World Evidence Manager
AstraZeneca